Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasrallah

Showing results (31-40 of 1,946) with videos related to

Pageof 195
Sort By:
CNS Spectrums|October 22, 2008
The urgent need for monitoring and intervention to reduce metabolic risk factors in patients with schizophreniaHenry A Nasrallah
Trends in Immunology|June 28, 2005
Recognition and rejection of self in plant self-incompatibility: comparisons to animal histocompatibilityJune B Nasrallah
Schizophrenia Research|February 24, 2009
Meta-analysis trends in schizophrenia over three decadesHenry A Nasrallah
Schizophrenia Research|October 1, 1991
Progressive and static ventriculomegaly in schizophrenia: clinical and methodological variablesH A Nasrallah
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1979
Tardive dyskinesia and depot fluphenazineH A Nasrallah
Asian Journal of Psychiatry|September 23, 2015
Toward the era of transformational neuropsychiatryHenry A Nasrallah
Ebiomedicine|January 26, 2022
Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?Gheyath K Nasrallah
Psychopharmacology Bulletin|October 1, 1979
Tardive dyskinesia symptomsH A Nasrallah
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 16, 2021
Re-inventing the DSM as a transdiagnostic model: Psychiatric disorders are extensively interconnectedHenry A Nasrallah
Schizophrenia Research|January 28, 2023
Is preventing the second psychotic episode a disease-modifying strategy for schizophrenia?Henry A Nasrallah
Pageof 195

Showing results (31-40 of 1,946) with videos related to

Sort By:
Pageof 195
CNS Spectrums|October 22, 2008
The urgent need for monitoring and intervention to reduce metabolic risk factors in patients with schizophreniaHenry A Nasrallah
Trends in Immunology|June 28, 2005
Recognition and rejection of self in plant self-incompatibility: comparisons to animal histocompatibilityJune B Nasrallah
Schizophrenia Research|February 24, 2009
Meta-analysis trends in schizophrenia over three decadesHenry A Nasrallah
Schizophrenia Research|October 1, 1991
Progressive and static ventriculomegaly in schizophrenia: clinical and methodological variablesH A Nasrallah
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1979
Tardive dyskinesia and depot fluphenazineH A Nasrallah
Asian Journal of Psychiatry|September 23, 2015
Toward the era of transformational neuropsychiatryHenry A Nasrallah
Ebiomedicine|January 26, 2022
Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?Gheyath K Nasrallah
Psychopharmacology Bulletin|October 1, 1979
Tardive dyskinesia symptomsH A Nasrallah
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 16, 2021
Re-inventing the DSM as a transdiagnostic model: Psychiatric disorders are extensively interconnectedHenry A Nasrallah
Schizophrenia Research|January 28, 2023
Is preventing the second psychotic episode a disease-modifying strategy for schizophrenia?Henry A Nasrallah
Pageof 195